Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety

Journal of Hepatology

Volumn 39, Issue 2, 2003, Pages 187-192

  Santos, Justiniano ^a   Planas, Ramon ^a   Pardo, Albert ^b   Durández, Rosa ^a   Cabré, Eduard ^a   Morillas, Rosa Maria ^a   Granada, Maria Luisa ^a   Jiménez, José Angel ^a   Quintero, Enrique ^b   Gassull, Miquel Angel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Ascites; Cirrhosis; Furosemide; Spironolactone

Indexed keywords

FUROSEMIDE; SPIRONOLACTONE;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERKALEMIA; HYPOKALEMIA; HYPONATREMIA; KIDNEY FAILURE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UREMIA;

EID: 10744226690     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(03)00188-0     Document Type: Article

References (26)

1. Arroyo V, Ginès V, Planas R, Panés J, Rodés J. Management of patients with cirrhosis and ascites. Semin Liver Dis 1986;6:353-69.
2. Ginès P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology 1987;7:122-8.
3. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
4. Arroyo V, Ginès P. Arteriolar vasodilatation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis. Gastroenterology 1992;102:1077-9.
5. Gatta A, Angeli P, Caregaro L, Menon F, Sacerdoti D, Merkel C. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991;14:231-6.
6. Perez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodés J. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Gastroenterology 1983;84:961-8.
7. Arroyo V, Ginès P, Planas R, Jiménez W, Rodés J. Ascites and renal dysfunction in cirrhosis. In: Bircher J, Benhamou JP, McIntyre N, Rizzeto M, Rodés J, editors. Oxford textbook of clinical hepatology, vol. I. Oxford: Oxford University Press; 1999. p. 697-761.
8. Angeli P, Gatta A. Medical treatment of ascites in cirrhosis. In: Arroyo V, Ginès P, Rodés J, Schrier RW, editors. Ascites and renal dysfunction in liver disease. Oxford: Blackwell Science; 1999. p. 442-62.
9. Bernardi M, Laffi G, Salvagnini M, Azzena G, Bonato S, Marra F, et al. Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. Liver 1993;13:156-62.
10. Fogel MR, Sawhney VK, Neal EA, Miller RG, Knauer CM, Gregory PB. Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol 1981;3 Suppl 1:73-80.
11. Asbert M, Jiménez W, Gaya J, Ginès P, Arroyo V, Rivera F, Rodés J. Assessment of the renin-angiotensin system in cirrhotic patients. J Hepatol 1992;15:179-83.
12. Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó LL, et al. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology 1988;8:636-42.
13. Inadomi J, Cello J, Koch J. Ultrasonographic determination of ascitic volume. Hepatology 1996;24:549-51.
14. Arroyo V, Ginès P, Gerbes A, Dudley F, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
15. Ginès P, Arroyo V, Rodés J. Pharmacotherapy of ascites associated with cirrhosis. Drugs 1992;43:316-32.
16. Angeli P, Gatta A, Caregaro L, Menon F, Sacerdoti D, Merkel C, Rondana M. Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur J Clin Invest 1990;20:111-7.
17. Angeli P, Caregaro L, Menon F, Sacerdoti D, De Toni R, Merkel C, Gatta A. Variability of atrial natriuretic peptide plasma levels in ascitic cirrhotics: pathophysiological and clinical implications. Hepatology 1992;16:1389-94.
18. Wong F, Tobe S, Legault L, Logan AG, Skorecki K, Blendis L. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation. Hepatology 1993;18:519-28.
19. Wilkinson SP, Williams R. Ascites, electrolyte disorders and renal failure. In: Wright R, Alberti KGMM, Karran S, Millward-Sadler GH, editors. Liver and biliary disease. Philadelphia, PA: Saunders; 1979. p. 1060-86.
20. Bernardi M, Santini C, Trevisani F, Baraldini M, Ligabue A, Gasbarrini G. Renal function impairment induced by change in posture in patients with cirrhosis and ascites. Gut 1985;26:629-35.
21. Arroyo V, Bosch J, Mauri M. Renin, aldosterone and renal hemodynamics in cirrhosis with ascites. Eur J Clin Invest 1979;9:69-73.
22. Stanley MM, Ochi S, Lee KK, Nemchausky BA, Greenlee HB, Allen JI, et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med 1989;321:1632-8.
23. Arroyo V, Epstein M, Gallus G. Refractory ascites in cirrhosis. Mechanism and management. Gastroenterol Int 1989;2:195-207.
24. Sherlock S, Senewiratne B, Scott A, Walker JG. Complications of diuretic therapy in hepatic cirrhosis. Lancet 1966;1:1049-53.
25. Strauss E, De Sa MG, Lacet CMC, Cartapatti Da Silva E, Dos Santos WR, Honain NZ, Maffei Jr RA. Standardization of a therapeutic approach for ascites due to chronic liver disease. A prospective study of 100 cases. Gastroenterol Endosc Digest 1985;4:79-86.
26. Ginès P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology 1987;93:234-41.